What is iRadimed's revenue?

iRadimed (IRMD) generated $86.3M in revenue over the trailing twelve months, up 14.8% year over year.

Is iRadimed profitable?

iRadimed reported $23.6M in net income over the trailing twelve months, a 27.4% net margin.

What are iRadimed's profit margins?

Gross margin is 76.8% and operating margin is 32.4%, with a 27.4% net margin.

What is iRadimed's earnings per share?

iRadimed's diluted EPS over the trailing twelve months is $1.83.

Where does iRadimed's income statement data come from?

Every line is extracted from iRadimed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

iRadimed IRMD Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$21.98M+12.6%	$22.69M+17.0%	$21.2M+15.7%	$20.41M+13.8%	$19.51M+10.9%
Total cost of revenue	$5.17M+10.6%	$5.66M+22.3%	$4.71M+13.9%	$4.45M+13.7%	$4.67M+10.9%
Gross profit	$16.81M+13.3%	$17.03M+15.4%	$16.49M+16.2%	$15.95M+13.9%	$14.84M+10.9%
Gross margin	76.5%+0.4pp	75.1%-1.1pp	77.8%+0.4pp	78.2%0.0pp	76.1%0.0pp
Research and development	$956K+53.2%	$799.03K+40.1%	$674.36K+5.5%	$877.36K+9.5%	$624K-24.0%
Selling and marketing	$4.05M-3.0%	$4.6M+1.9%	$4.63M+22.0%	$4.01M+15.3%	$4.18M+9.1%
General and administrative	$4.57M-0.9%	$4.54M+17.1%	$4.36M+9.8%	$4.28M+4.3%	$4.61M+15.5%
Total operating expenses	$9.58M+1.8%	$9.94M+10.9%	$9.66M+15.0%	$9.17M+9.4%	$9.41M+8.9%
Operating income	$7.24M+33.2%	$7.09M+22.3%	$6.83M+18.0%	$6.79M+20.6%	$5.43M+14.4%
Operating margin	32.9%+5.1pp	31.3%+1.3pp	32.2%+0.6pp	33.3%+1.9pp	27.8%+0.9pp
Other income (expense), net	$532K+3.7%	$696.8K+28.2%	$463.98K-26.3%	$539.25K-16.0%	$513K+3.6%
Income before income taxes	$7.77M+30.7%	$7.79M+22.8%	$7.3M+13.7%	$7.33M+16.9%	$5.95M+13.4%
Income tax expense	$1.95M+55.1%	$1.35M+12.7%	$1.72M+25.7%	$1.55M+13.5%	$1.26M+13.6%
Net income	$5.82M+24.1%	$6.44M+25.2%	$5.58M+10.4%	$5.77M+17.8%	$4.69M+13.3%
Net margin	26.5%+2.4pp	28.4%+1.8pp	26.3%-1.3pp	28.3%+1.0pp	24%+0.5pp
Diluted earnings per share	$0.45+21.6%	$0.50+25.0%	$0.43+7.5%	$0.45+18.4%	$0.37+15.6%
EBITDA	$7.69M+36.7%	$7.47M+24.7%	$7.22M+20.6%	$7M+20.1%	$5.63M+13.1%
EBITDA margin	35%+6.2pp	32.9%+2.0pp	34%+1.4pp	34.3%+1.8pp	28.8%+0.6pp
EBIT	$7.24M+33.2%	$7.09M+22.3%	$6.83M+18.0%	$6.79M+20.6%	$5.43M+14.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about iRadimed.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is iRadimed's revenue?: iRadimed (IRMD) generated $86.3M in revenue over the trailing twelve months, up 14.8% year over year.
Is iRadimed profitable?: iRadimed reported $23.6M in net income over the trailing twelve months, a 27.4% net margin.
What are iRadimed's profit margins?: Gross margin is 76.8% and operating margin is 32.4%, with a 27.4% net margin.
What is iRadimed's earnings per share?: iRadimed's diluted EPS over the trailing twelve months is $1.83.
Where does iRadimed's income statement data come from?: Every line is extracted from iRadimed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.